Metastatic Breast Cancer

Watch Dr. Keerthi Gogineni, from Emory University School of Medicine, discuss the management of triple-negative disease, during the CURE Educated Patient Metastatic Breast Cancer Summit.

Watch Dr. Suchita Pakkala, from Emory University School of Medicine, discuss estrogen receptor-positive disease, during the CURE Educated Patient Metastatic Breast Cancer Summit.

In CURE®’s “Speaking Out” video series, on behalf of Living Beyond Breast Cancer, Dr. Nancy Lin discusses treatment planning for brain metastases in breast cancer and how patients can take part in driving their care.

I hope every patient and their family can feel the caring that two angels standing by a shoulder can bring.

After surviving cancer, I knew what medical upselling looked like, and experienced it firsthand when a clinician tried to send me for more tests than I felt necessary.

Cancer and its treatments can affect oral health, though when I was diagnosed with breast cancer, the thought of seeing the dentist slipped my mind.

Getting other medical opinions for my cancer diagnosis not only saved my life but also taught me self-care.

The findings of the study show that Enhertu should be a new standard of care for patients with HER2-low metastatic breast cancer, according to an expert at Memorial Sloan Kettering Cancer Center.

At a follow-up of more than two years, treatment with a novel drug produced meaningful results in a group of patients with HER3-expressing metastatic breast cancer or metastatic triple-negative breast cancer.

Treatment with Trodelvy resulted in slight survival improvements, when compared with standard of care chemotherapy regimens, in patients with hormone receptor–positive, HER2-negative metastatic breast cancer.

I’m not going to worry that I’m changing my own health by saying out loud that this cancer stuff is hard and scary and kills way too many people every single day.

When I was diagnosed with metastatic breast cancer, my oncology nurse ended up becoming a trusted friend.

A small percentage of patients with metastatic breast cancer participating in clinical trials in the U.S. are Black, which, according to a patient living with the disease is a huge concern since it doesn’t represent the general population.

When I was diagnosed with stage 4 cancer, I was comforted by a simple phrase my oncologist told my husband.

Updated trial results showed that the use of Kisqali plus fulvestrant was associated with an approximate 33% decrease in risk of death for women with HR-positive, HER2-negative advanced breast cancer.

After Enhertu showed promising clinical trial results, the Food and Drug Administration agreed to speed up the development and review of the drug for certain patients with unresectable or metastatic breast cancer.

When I was first diagnosed with metastatic breast cancer, I did not know there were so many other people like me until I attended Living Beyond Breast Cancer’s Conference on Metastatic Breast Cancer.

The Food and Drug Administration granted a fast-track designation to Bria-IMT for the treatment of patients with metastatic breast cancer.

Over the past several years, multiple treatment advancements have given oncologists the ability to better target brain metastases in patients with HER2-positive metastatic breast cancer.

The most revealing thing that Dr. Bhuvaneswari Ramaswamy, a breast medical oncologist, learned during her own treatment for breast cancer was that despite having extraordinary family and medical support, she still felt very isolated.

Dr. Nancy U. Lin actors as a mentor for her patients, helping to guide them through the cancer experience, says her colleague Dr. Ines Vaz-Luis.

Treatment with Enhertu was associated with improved survival across several subgroups of patients with metastatic breast cancer, compared with standard-of-care chemotherapy.

Dr. Nancy U. Lin dedicated her life to improving outcomes for patients with metastatic breast cancer. In this essay, a colleague honors her hard work.

"Because of his supportive rapport with his patients, his name often has come up in our local support group, resulting in everyone wishing they had 'a Gil,'" a cancer survivor wrote of a clinical trial research nurse.

A woman with metastatic breast cancer pens a heartfelt tribute to the oncologist who saved her life and approached her care with empathy and encouragement.

A colleague recognizes the generosity, humility and grace of a metastatic breast cancer expert who has led many practice-changing trials and programs to help as many patients as she can.

When I first learned about my mom’s breast cancer, I was just a toddler — but thanks to her incredible oncologist, my mom is here to see to me grow up.

A surgical oncologist honors an admirable doctor in the field who refuses to falter in the face of challenges in order to do exhaust every opportunity possible to improve the lives of patients with metastatic breast cancer.

A woman with breast cancer honors a colleague for her inspirational work to better the lives of patients with metastatic breast cancer, mentor others and inspire meaningful change.

I feared that switching to a new oncologist after mine retired would be awkward but having Dr. Joshua D. Rosenberg treat my metastatic breast cancer has left me with the deepest gratitude.